Medical Xpress October 1, 2021
With new COVID-19 cases remaining at high levels across the U.S., new drug therapies that may help people who contract the respiratory disease evade serious illness are starting to garner more attention.
The World Health Organization recently endorsed an antibody drug cocktail made by Regeneron Pharmaceuticals, a combination drug that has been used widely to bolster sick patients by infusing them with antibodies designed to combat COVID. And a new antiviral pill that could be taken daily, called molnupiravir, is being studied as a way of halting COVID illness early in its course.
While these treatments for COVID have helped to shore up hospital resources by preventing severe illness in many patients, they are far from a silver bullet, and...